Safety and Efficacy of Fremanezumab for the Prevention of Migraine: A Meta-Analysis From Randomized Controlled Trials

Background: Fremanezumab (TEV-48125) is a fully-humanized immunoglobulin G isotype 2a selective monoclonal antibody that potently binds to calcitonin gene-related peptide (CGRP). It is one of the novel therapeutic drugs for the prevention of migraine, which is one of the most common neurological dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Bixi, Sun, Nan, Yang, Yanbo, Sun, Yue, Chen, Mingjia, Chen, Zhouqing, Wang, Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248404/
https://www.ncbi.nlm.nih.gov/pubmed/32508742
http://dx.doi.org/10.3389/fneur.2020.00435

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248404/
https://www.ncbi.nlm.nih.gov/pubmed/32508742
http://dx.doi.org/10.3389/fneur.2020.00435

Ejemplares similares